In a 7‑year‑old girl presenting with hand‑foot‑and‑mouth disease, what differential diagnoses should be considered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnoses for Hand-Foot-and-Mouth Disease in a 7-Year-Old

When evaluating a 7-year-old presenting with suspected hand-foot-and-mouth disease, you must actively exclude other enteroviral infections, meningococcemia, Rocky Mountain spotted fever, Kawasaki disease, drug reactions, and streptococcal exanthems—all of which can present with similar palmar-plantar rashes and fever.

Critical Life-Threatening Differentials to Rule Out First

Meningococcemia (Neisseria meningitidis)

  • Most urgent differential due to rapid progression and high mortality 1
  • Both meningococcemia and RMSF begin as maculopapular rash and progress to petechial rash
  • Key distinction: Meningococcemia progresses much more rapidly than other causes 1
  • Look for: Rapid clinical deterioration, altered mental status, signs of shock, purpuric lesions that don't blanch

Rocky Mountain Spotted Fever (RMSF)

  • Critical to consider in endemic areas during tick season (spring/summer) 1
  • Rash typically appears 2-4 days after fever onset (not simultaneously) 1
  • Initial rash: small blanching pink macules on ankles, wrists, forearms that evolve to maculopapules 1
  • Palms/soles involvement occurs late (day 5-6) in only 50% of cases 1
  • Associated with: severe headache, high fever, shaking chills, myalgias 1
  • Laboratory clues: thrombocytopenia (platelet count <150,000), normal WBC with bandemia 1
  • Common pitfall: 20% have no rash or atypical rash 1

Other Infectious Differentials

Atypical Hand-Foot-Mouth Disease (Coxsackievirus A6)

  • Increasingly common cause of severe, widespread vesiculobullous eruptions 2, 3, 4
  • Key differences from classic HFMD:
    • More extensive distribution beyond typical sites
    • Frequent perioral lesions
    • Painful eruptions requiring hospitalization in some cases 3
    • Can mimic eczema herpeticum, varicella, disseminated zoster, erythema multiforme 4
    • Post-infectious nail changes (onychomadesis) 4-6 weeks later 2, 5

Other Enteroviral Infections

  • Herpangina (oral lesions without hand/foot involvement) 6
  • Echovirus and other coxsackieviruses can cause palmar-plantar rash 1
  • Generally milder systemic symptoms than RMSF or meningococcemia

Streptococcal Disease

  • Group A streptococcal pharyngitis with exanthem 1
  • Can present with fever, sore throat, and rash
  • Petechial rash possible after streptococcal pharyngitis 1
  • Obtain rapid strep test and throat culture

Inflammatory/Immune-Mediated Conditions

Kawasaki Disease

  • Critical not to miss due to coronary artery complications 1
  • Requires fever ≥5 days plus ≥4 of: conjunctivitis (bilateral, non-exudative), oral changes (cracked lips, strawberry tongue), polymorphous rash, extremity changes (erythema/edema of hands/feet), cervical lymphadenopathy ≥1.5 cm 7
  • Key distinction from HFMD: no vesicles, more prominent mucosal inflammation, longer fever duration
  • Laboratory: elevated inflammatory markers, thrombocytosis in second week 7

Multisystem Inflammatory Syndrome in Children (MIS-C)

  • Consider if COVID-19 exposure within 4 weeks 8
  • Overlapping features with Kawasaki disease: rash, conjunctivitis, mucocutaneous inflammation, extremity changes 8
  • More prominent GI symptoms, cardiac dysfunction, shock than classic KD 8
  • Broader age range affected than typical KD 8

Drug Hypersensitivity Reactions

  • Palmar-plantar rash can occur with drug reactions 1
  • Obtain detailed medication history including over-the-counter medications
  • Consider Stevens-Johnson syndrome/toxic epidermal necrolysis if mucosal involvement severe

Additional Differentials Based on Clinical Context

Secondary Syphilis (Treponema pallidum)

  • Palmar-plantar rash is classic 1
  • Consider in adolescents or if maternal transmission suspected
  • Associated with generalized lymphadenopathy, condyloma lata

Other Conditions

  • Parvovirus B19: "slapped cheek" appearance, lacy reticular rash on extremities 1
  • Mycoplasma pneumoniae: respiratory symptoms predominate 1
  • Erythema multiforme: target lesions, often drug or HSV-triggered 6
  • Dyshidrosis: chronic vesicular eruption of palms/soles without fever 6

Diagnostic Approach Algorithm

  1. Assess severity immediately: Signs of shock, altered mental status, rapid progression → treat empirically for meningococcemia/RMSF
  2. Timing of rash relative to fever:
    • Simultaneous onset → more likely viral (HFMD, other enteroviruses)
    • Rash 2-4 days after fever → consider RMSF 1
  3. Rash characteristics:
    • Vesicular on hands/feet/mouth → HFMD (classic or atypical)
    • Petechial/purpuric → meningococcemia, RMSF, enterovirus
    • No vesicles but mucosal changes → Kawasaki disease
  4. Epidemiologic clues:
    • Tick exposure/endemic area → RMSF 1
    • Recent COVID-19 exposure → MIS-C 8
    • Sick contacts with similar illness → enteroviral infection
  5. Laboratory evaluation (if diagnosis uncertain):
    • CBC with differential, CRP, ESR, comprehensive metabolic panel 1
    • Blood culture
    • Throat culture/rapid strep test
    • Consider SARS-CoV-2 testing if MIS-C suspected 8

Common pitfall: Assuming all palmar-plantar rashes in children are benign HFMD—always consider life-threatening causes first, especially with high fever, systemic symptoms, or atypical features.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.